Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 161113 | SCH 546738 | 906805-42-3 | 98% |  |
| SCH 546738 is a novel, potent and non-competitive small molecule CXCR3 antagonist wit | ||||
| 611937 | 4SC-202 | 1186222-89-8 | 98% |  |
| 4SC-202 is an orally available potent HDACi specific for class I HDAC isoenzymes(NO H | ||||
| 611930 | SJB3-019A | 98% |  | |
| SJB3-019A is a potent and novel usp1 inhibitor. SJB3-019A (IC50 = 0.0781 uM) was 5 ti | ||||
| 611915 | SR-3029 | 1454585-06-8 | 98% | |
| SR 3029 is a potent and highly specific CK1/CK1 inhibitor with the IC50 of 97 nM.SR-3 | ||||
| 161009026 | SB-216763 | 280744-09-4 | 98% by HPLC |  |
| SB-216763 is a glycogen synthase kinase-3 (GSK3) inhibitor, which can maintain mouse | ||||
| 161009025 | SC79 | 305834-79-1 | 98% by HPLC |  |
| Akt Activator II, SC79, CAS 305834-79-1, is a cell-permeable compound that interacts | ||||
| 161009003 | Sirolimus (Rapamycin) | 53123-88-9 | 98% by HPLC | -cas-53123-88-9.png) |
| In cells, sirolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to gene | ||||
| 16082501 | Serlopitant(VPD-737) | 860642-69-9 | 98% by HPLC | -cas-860642-69-9.png) |
| Serlopitant (VPD-737) is a drugwhich acts as an NK1 receptor antagonist. It was asses | ||||
| 16071406 | SH-4-54 | 1456632-40-8 | 98% by HPLC | |
| SH-4-54 is a potent STAT inhibitor with KD of 300 nM and 464 nM for STAT3 and STAT5, | ||||
| 16071404 | Siponimod | 1230487-00-9 | 98% |  |
| Siponimod, also known as BAF-312, is a a potent and orally selective S1P Receptor Mod | ||||
| 16071023 | SAR125844 | 1116743-46-4 | 98% by HPLC |  |
| SAR125844 is a potent and highly selective c-Met inhibitor with potential antineoplas | ||||
| 16071014 | SRT2104 | 1093403-33-8 | 98% by HPLC |  |
| SRT2104, also known as GSK2245840, is a novel, first-in-class, highly selective small | ||||
| 16071007 | Scriptid | 287383-59-9 | 98% by HPLC |  |
| Scriptid | ||||
| 16071004 | Sotrastaurin | 425637-18-9 | 98% by HPLC |  |
| Sotrastaurin, also known as AEB-071, is an orally available pan-protein kinase C (PKC | ||||
| 16071002 | SR-2211 | 1359164-11-6 | 98% by HPLC | |
| SR-2211 | ||||
| 16070912 | SGX-523 | 1022150-57-7 | 98% by HPLC |  |
| SGX523 is a novel, ATP-competitive kinase inhibitor remarkable for its exquisite sele | ||||
| 16070911 | SEA0400 | 223104-29-8 | 98% by HPLC |  |
| SEA0400 is a Na+/Ca2+ exchanger 1 inhibitor. SEA0400 prevents dopaminergic neurotoxic | ||||
| 16070908 | SR 11302 | 160162-42-5 | 98% by HPLC |  |
| SR 11302 | ||||
| 16070907 | Sobetirome | 211110-63-3 | 98% by HPLC |  |
| Sobetirome, also known as GC-1 and QRX-431, is a hyroid hormone beta-receptor agonist | ||||
| 16070902 | SGI 7079 | 1239875-86-5 | 98% by HPLC |  |
| SGI 7079 | ||||
| 16070103 | SCH23390 | 125941-87-9 | 98% by HPLC |  |
| SCH23390 | ||||
| 16062905 | SKF-96365 HCl | 130495-35-1 | 98% by HPLC |  |
| SKF-96365 is a selective TRPC channel blocker. SKF-96365 activates cytoprotective aut | ||||
| 16062201 | Simeprevir | 923604-59-5 | 98% by HPLC |  |
| Simeprevir (formerly TMC435; trade name Olysio) is a drug for the treatment and cure | ||||
| 16062106 | (S)-4-tert-Butyl-2-[(SP)-2-(diphenylphosphino)ferrocenyl]-2-oxazoline | 163169-15-1 | 98% by HPLC | -4-tert-Butyl-2-[(SP)-2-(diphenylphosphino)ferrocenyl]-2-oxazoline-cas-163169-15-1.png) |
| (S)-4-tert-Butyl-2-[(SP)-2-(diphenylphosphino)ferrocenyl]-2-oxazoline | ||||
| 16060802 | SCH-58261 | 160098-96-4 | 98% by HPLC |  |
| SCH-58261 is a potent and selective adenosine A(2A) receptor antagonist. SCH-58261 is | ||||
| 031703 | Sapacitabine | 151823-14-2 | 98% |  |
| Sapacitabine is an orally bioavailable pyrimidine analogue prodrug with potential ant | ||||
| 031701 | Saquinavir Mesylate | 149845-06-7 | 98% |  |
| Saquinavir mesylate is an HIV protease inhibitor which acts as an analog of an HIV pr | ||||
| 030908 | SR9009 | 1379686-30-2 | 98% |  |
| Coming soon! | ||||
| 030903 | S-4 | 401900-40-1 | 98% |  |
| Coming soon! | ||||
| 020105 | Selexipag | 475086-01-2 | 98% |  |
| Selexipag is a a first-in-class orally available selective non-prostanoid IP receptor | ||||